LIVER ALLOGRAFT

Clinical trials for LIVER ALLOGRAFT explained in plain language.

Never miss a new study

Get alerted when new LIVER ALLOGRAFT trials appear

Sign up with your email to follow new studies for LIVER ALLOGRAFT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

A new Anti-Rejection strategy may spare kidney function after liver transplant

Disease control Not yet recruiting

This phase III trial is testing whether switching liver transplant recipients to an everolimus-based, calcineurin inhibitor-free regimen one year after surgery can better preserve kidney function compared to staying on a low-dose calcineurin inhibitor. The study enrolls 150 adult…

Matched conditions: LIVER ALLOGRAFT

Phase: PHASE3 • Sponsor: Hannover Medical School • Aim: Disease control

Last updated Aug 02, 2026 00:00 UTC

LIVER ALLOGRAFT

Get alerted when new LIVER ALLOGRAFT trials appear

A new Anti-Rejection strategy may spare kidney function after liver transplant